Leveraging Technology and Partnerships to Improve Medical Care​

Leveraging Technology and Partnerships to Improve Medical Care​

With the fast pace of changing healthcare, the use of new and existing technology has helped to advance patient care as well as forging new partnerships between the pharmaceutical industry and technology corporations.  Dr. Maria Rivas, Senior Vice-President, Global Medical Affairs, Merck will be speaking on this exciting topic and giving examples of why and how the future of patient care has been influenced by the advances in technology and why pharma companies have decided to utilize this technology to help with advances in drug development and new initiatives in medicine.

Lecture: 6:30pm | Dinner: 7:30pm

This event is co-sponsored with the Columbia Club of NY Health and Wellness Committee.

Login and register for this event. (Not a Penn Club member yet?  Click here to get started today!)

Biography
Maria Rivas MD FACP FACE
Senior Vice President Global Medical Affairs, Merck

Dr. Maria Rivas currently leads the Global Medical Affairs (GMA) organization at Merck. As an organization of more than 1400 colleagues, GMA serves as a strategic partner to the Merck Global, Regional and Country commercial organizations and the Merck Research Laboratory to provide high quality scientific and value evidence information to physicians, patients and payers. GMA also generates scientific information and engages in scientific exchange with customers to improve patient outcomes and access to innovative therapies.

She previously served as Vice President of Global Medical Affairs at Abbvie, where she started and transformed the company’s first global medical affairs organization. Before joining Abbvie, she was Vice President and Head of Medical Affairs for the Global Oncology, the US General Medicine, and the US Diagnostic Imaging franchises at Bayer Healthcare. She started her career in pharmaceuticals at Eli Lilly, where she held increasingly senior roles in Medical Affairs and Clinical Development over 11 years. She is an expert in global organization start-ups and turnarounds, and in managing patient safety, regulatory, quality and compliance issues in US and internationally. She has a reputation in the industry for being a dedicated and caring leader and business partner, and working with the highest regard for ethics and the patients’ well-being.

Dr. Rivas is a US trained, board-certified endocrinologist. She received her BA in Biochemistry from Brandeis University in Massachusetts and her MD from Columbia University-College of Physicians & Surgeons in New York. She completed her Internal Medicine residency and Endocrinology fellowship at The Presbyterian Hospital in New York.
Dr. Rivas serves as Trustee of the Merck Foundation and the Merck Patient Assistance Program. She is fully bilingual in English and Spanish and has served as company spokesperson in the US and international lay media in both languages.